Creative Biolabs stands as a trusted partner for ADC discovery through its specialized knowledge base and state-of-the-art technology combined with a dedication to client needs. We use advanced yeast display technology to advance both antibody discovery and optimization processes while making ADC development more efficient.
This antibody selection process allows for the identification of candidates with prime affinity, specificity, and stability which are crucial for developing advanced targeted therapies. Our approach to minimizing antibody self-association helps us produce top-quality candidates required to achieve successful ADC development.
| Step | Description |
| Required Starting Materials |
- Purified target antigen (protein, peptide, cell or other complex antigens). - Detailed target information if available (sequence, structure, biological context). - Existing antibody leads or research data if available. |
| 1. Consultation & Project Design | - Collaborate to define targets, scope, and deliverables. |
| 2. Target Antigen Preparation | - Define and prepare target antigen for optimal antibody selection. |
| 3. Custom Antibody Library Generation | - Create a high-diversity, tailored antibody library for your target. |
| 4. Yeast Display Screening & Selection | - Display antibody library on yeast cells and sort high-affinity candidates. |
| 5. Characterization & Validation | - Assess affinity (KD), specificity, epitope mapping, and cross-reactivity. |
| 6. Affinity Maturation & Optimization | - Optimization of stability and affinity, ensuring superior performance in ADC applications. |
| 7. ADC Construct Design & Evaluation | - Design and evaluate ADC constructs, optimizing drug conjugation and stability. |
| 8. Final Deliverables | - Prepare detailed reports with antibody sequences, affinity data, specificity profiles. |
We provide a comprehensive suite of yeast display-based antibody discovery services to advance your research and therapeutic projects, including but not limited to:
Antibody-Drug Conjugates (ADCs) provide targeted cancer treatment by fusing monoclonal antibodies with cytotoxic drugs which minimizes harm to healthy cells. Functional ADC development requires discovering antibodies with both high-affinity binding to tumors and specific targeting capabilities.
The Yeast Display ADC Discovery Service streamlines antibody identification through yeast display technology which allows for high-throughput screening of extensive antibody collections. Yeast display technology allows for eukaryotic post-translational modifications that yield functional and stable antibodies unlike older methods. Antibody fragment presentation on yeast cells enables swift identification of optimal candidates which speeds up ADC development and enhances therapeutic results.
Creative Biolabs gives you precisely targeted innovative solutions made to accelerate your ADC research process. Contact our team today to discuss your project details and explore our ways to help you meet your development goals.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.